LPS에 의해 유도된 인지기능 손상모델에 대한 천마 추출물의 방어효과
Protective Effect of Gatrodiae Rhizoma Extracts on the LPS-Induced Cognitive Impairment Model
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Gastrodia elata (GE) has been used to treat cognition impairment, including Alzheimer’s disease (AD) in Korea. The purpose of this study was to investigate the effects of GE water extracts (GEE) on the lipopolysaccharide (LPS)-induced AD model in mice. (Aβ). Methods: We classified six groups as follow; group 1: control (CON), group 2: LPS (0.5 mg/kg/day, four times), group 3: 4 mg/kg donepezil (DP), group 4: 100 mg/kg GEE+LPS, group 5: 200 mg/kg GEE+LPS, group 6: 500 mg/kg GEE+LPS. Results: We found that GEE has an effect that inhibits decrease of discrimination index in object recognition test, as well as spontaneous alteration in the Y-maze test by LPS. Treatment with LPS increased amlyloid-β (Aβ) concentration, and decreased brain-derived neurotrophic factor (BDNF) in cerebral cortex of mice. However, GEE significantly protected against LPS-induced Aβ and BDNF changes. Our findings also showed that the inflammatory cytokines 〔tumor necrosis factor-alpha (TNF-α), interleukin- 6 (IL-6) and interleukin-1β (IL-1β)〕 mRNA and protein were up-regulated by the LPS injection. But GEE significantly suppressed LPS-induced inflammatory cytokines increase in a dose-dependent manner. Conclusions: This study suggests that the GEE may be an effective AD therapeutic agent, in treating neurodegenerative diseases including AD.
Abstract
Objectives: Gastrodia elata (GE) has been used to treat cognition impairment, including Alzheimer’s disease (AD) in Korea. The purpose of this study was to investigate the effects of GE water extracts (GEE) on the lipopolysaccharide (LPS)-induced AD model in mice. (Aβ). Methods: We classified six groups as follow; group 1: control (CON), group 2: LPS (0.5 mg/kg/day, four times), group 3: 4 mg/kg donepezil (DP), group 4: 100 mg/kg GEE+LPS, group 5: 200 mg/kg GEE+LPS, group 6: 500 mg/kg GEE+LPS. Results: We found that GEE has an effect that inhibits decrease of discrimination index in object recognition test, as well as spontaneous alteration in the Y-maze test by LPS. Treatment with LPS increased amlyloid-β (Aβ) concentration, and decreased brain-derived neurotrophic factor (BDNF) in cerebral cortex of mice. However, GEE significantly protected against LPS-induced Aβ and BDNF changes. Our findings also showed that the inflammatory cytokines 〔tumor necrosis factor-alpha (TNF-α), interleukin- 6 (IL-6) and interleukin-1β (IL-1β)〕 mRNA and protein were up-regulated by the LPS injection. But GEE significantly suppressed LPS-induced inflammatory cytokines increase in a dose-dependent manner. Conclusions: This study suggests that the GEE may be an effective AD therapeutic agent, in treating neurodegenerative diseases including AD.
참고문헌 (20)
- Mattson MP, "Pathways towards and away from Alzheimer’s disease", Nature, 430(7000), pp.631~639 (2004)
- Alonso AC, "Alzheimer’s disease hyperphosphorylated Tau sequesters normal Tau into tangles of filaments and disassembles microtubules", Naturee Medicine, 2(7), pp.783~787 (1996)
- Lorenzo A, "β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red", Proceedings of the National Academy of Sciences, 91(25), pp.12243~12247 (1994)
- Thoenen H, "Neurotrophins and activity-dependent plasticity", Progress in Brain Research, 128, pp.183~191 (2000)
- Schinder AF, "The neurotrophin hypothesis for synaptic plasticity", Trends in Neurosciences, 23, pp.639~645 (2000)
- Streit WJ, "Microglia and neuroinflammation : A pathological perspective", Journal of Neuroinflammation, 14, pp.1~4 (2004)
- Lu YC, "Lps", tlr4 signal transduction pathway, 2008, pp.42, 145~151
- Fiebich BL, "Role of microglia tlrs in neurodegeneration", Frontiers in Cellular Neuroscience, 12, pp.329~ (2018)
- Taguchi H, "Studies on the constituents of Gastrodia elata BLUME", Chemical and Pharmaceutical Bulletin, 29, pp.55~62 (1981)
- 정영수, "癡呆病態모델에서 天麻의 神經細胞 損傷 保護效果", 동의신경정신과학회지, 21(2), pp.125~140 (2010), 대한한방신경정신과학회
- 윤유석, "천마가 중대뇌동맥 폐쇄 흰쥐의 신경세포 자연사에 미치는 영향", 한방재활의학과학회지, 19(3), pp.1~13 (2009), 한방재활의학과학회
- 김우철, "천마를 이용한 기억력 향상 효과 연구", 동의신경정신과학회지, 24(1), pp.27~43 (2013), 대한한방신경정신과학회
- 김하나, "천마의 용량에 따른 기억력 향상 효과에 대한 연구", 동의신경정신과학회지, 25(3), pp.243~252 (2014), 대한한방신경정신과학회
- Alzheimer’s Association, "2012 Alzheimer’s disease facts and figures", Alzheimer’s & Dementia, 8(2), pp.131~168 (2012)
- Rafii MS, "Advances in Alzheimer’s disease drug development", BMC Medicine, 13(1), pp.62~ (2015)
- Zhao J, "Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice", Scientific Reports, 9, pp.5790~ (2019)
- Wu PL, "Effectiveness of physical activity on patients with depression and Parkinson’s disease : A systematic review", PLoS ONE, 12, pp.e0181515~ (2017)
- Galts CP, "Depression in neurodegenerative diseases: Common mechanisms and current treatment options", Neuroscience & Biobehavioral Reviews, 102, pp.56~84 (2019)
- Jin Y, "The role of BDNF in the neuroimmune axis regulation of mood disorders", Frontiers in Neurology, 10, pp.515~ (2019)
- Kim MW, "Pharmacological Inhibition of Spleen Tyrosine Kinase Suppressed Neuroinflammation and Cognitive Dysfunction in LPS-Induced Neurodegeneration Model", Cells, 11(11), pp.1777~ (2022)